phenol has been researched along with Dyskinesia Syndromes in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Consensus dosing guidelines have been developed and are presented within." | 2.42 | Injectable neuromuscular blockade in the treatment of spasticity and movement disorders. ( Tilton, AH, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tilton, AH | 1 |
1 review available for phenol and Dyskinesia Syndromes
| Article | Year |
|---|---|
Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
Topics: Anti-Dyskinesia Agents; Botulinum Toxins; Central Nervous System Depressants; Drug Administration Sc | 2003 |